Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E G Mansour

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer|January 15, 1994
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifenK E Gale, J W Andersen, D C Tormey, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1996
Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, H Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinomaD C Allred, G M Clark, A K Tandon, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076)L G Dressler, L Eudey, R Gray, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
Surgery|October 1, 1990
Short-term tamoxifen plus chemotherapy: superior results in node-positive breast cancerJ P Crowe, N H Gordon, R R Shenk, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patientsG M Clark, M C Mathieu, M A Owens, et al.
Surgery|July 1, 1984
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-upC A Hubay, N H Gordon, J P Crowe, et al.
Human Pathology|February 1, 1982
Interobserver variation in the identification of breast carcinoma in intramammary lymphaticsK W Gilchrist, V E Gould, S Hirschl, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer|January 15, 1994
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifenK E Gale, J W Andersen, D C Tormey, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1996
Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, H Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinomaD C Allred, G M Clark, A K Tandon, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076)L G Dressler, L Eudey, R Gray, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
Surgery|October 1, 1990
Short-term tamoxifen plus chemotherapy: superior results in node-positive breast cancerJ P Crowe, N H Gordon, R R Shenk, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patientsG M Clark, M C Mathieu, M A Owens, et al.
Surgery|July 1, 1984
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-upC A Hubay, N H Gordon, J P Crowe, et al.
Human Pathology|February 1, 1982
Interobserver variation in the identification of breast carcinoma in intramammary lymphaticsK W Gilchrist, V E Gould, S Hirschl, et al.
Pageof 4